Differences among hemoglobin thresholds for red blood cell transfusions in patients with hematological diseases in teaching hospitals: a real world data in Japan

• Published in: International journal of hematology 2020-10, Vol.112 (4), p.535-543
• Main Authors: Yokohama, Akihiko, Okuyama, Yoshiki, Ueda, Yasunori, Itoh, Masumi, Fujiwara, Shin-ichiro, Hasegawa, Yuichi, Nagai, Kazuhiro, Arakawa, Kimika, Miyazaki, Koji, Makita, Masanori, Watanabe, Mai, Ikeda, Kazuhiko, Tanaka, Asashi, Fujino, Keizo, Matsumoto, Mayumi, Makino, Shigeyoshi, Kino, Shuichi, Takeshita, Akihiro, Muroi, Kazuo
• Format: Article
• Language: English
• Subjects: Hematology; Medicine; Medicine & Public Health; Oncology; Original Article
• ISSN: 0925-5710; 1865-3774
• DOI: 10.1007/s12185-020-02937-3

A hemoglobin (Hb) threshold level of 7 g/dL has been proposed for red blood cell (RBC) transfusion in patients with chronic anemia in the Japanese guideline since 2005. However, Hb thresholds for hematological diseases in clinical practice and factors responsible for higher Hb thresholds remain unclear. Hb thresholds were collected for patients with hematological diseases from 32 Japanese teaching hospitals. Uni- and multivariate analyses were used to analyze relationships between Hb threshold level and various patient and hospital factors. In total, 4996 units of RBC were transfused to 1054 patients with hematological diseases in 2421 transfusions. Median age was 68 years. Myelodysplastic syndrome was the most frequent diagnosis. Overall median Hb threshold level was 6.9 g/dL. Multivariate linear regression analysis detected the following variables associated with Hb threshold level: hospital; cardiovascular disease; symptomatic anemia; and hematopoietic stem cell transplantation. Hospital was the most significant factor. Collectively, median Hb threshold level in clinical practice in Japan was similar to the guidelines. Higher Hb threshold level depended on the hospitals at which the transfusions were performed as well as patient condition. Educational approaches directed toward hospitals may be useful to promote transfusion guidelines.